(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
AN2 Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
---|---|---|---|---|---|---|---|---|
Friday, April 26th, 2024 | 2023 | Eric Easom President and Chief Executive Officer | 575,000 | 0 | 0 | 345,000 | 0 | 3,342,848 |
Friday, April 26th, 2024 | 2022 | Eric Easom President and Chief Executive Officer | 481,185 | 0 | 0 | 216,533 | 0 | 3,465,533 |
Friday, April 26th, 2024 | 2023 | Lucy Day Chief Financial Officer | 430,000 | 0 | 0 | 206,400 | 0 | 1,524,458 |
Friday, April 26th, 2024 | 2022 | Lucy Day Chief Financial Officer | 379,934 | 0 | 0 | 136,776 | 0 | 1,328,603 |
Friday, April 26th, 2024 | 2023 | Paul Eckburg, M.D. Chief Medical Officer | 465,000 | 0 | 0 | 223,200 | 0 | 1,453,786 |
Friday, April 26th, 2024 | 2022 | Paul Eckburg, M.D. Chief Medical Officer | 427,399 | 0 | 0 | 153,864 | 0 | 1,393,156 |
Wednesday, April 26th, 2023 | 2021 | Paul Eckburg, M.D. Chief Medical Officer | 258,125 | 0 | 0 | 77,000 | 0 | 903,053 |
Wednesday, April 26th, 2023 | 2022 | Joshua Eizen, J.D. Chief Legal Officer | 101,742 | 0 | 0 | 36,627 | 0 | 1,354,563 |
Wednesday, April 26th, 2023 | 2022 | Eric Easom President, Chief Executive Officer and Director | 481,185 | 0 | 0 | 216,533 | 0 | 3,465,533 |
Wednesday, April 26th, 2023 | 2021 | Eric Easom President, Chief Executive Officer and Director | 377,300 | 0 | 0 | 151,000 | 0 | 1,718,989 |
Wednesday, April 26th, 2023 | 2022 | Paul Eckburg, M.D. Chief Medical Officer | 427,399 | 0 | 0 | 153,864 | 0 | 1,393,156 |